| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
| mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.8 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.0093 |
0.9 |